Global Clot Management Devices Market
Global Clot Management Devices Market was valued at USD 1.6 billion in 2021 and would rocket up to USD 2.2 billion by 2027 at a CAGR of 5.5% from 2022-2027.
A clot of blood develops at the end of the hemostasis process. Clots are also referred to as "thrombus." Red blood cells and clumped platelets make up a blood clot, and they work together to produce a plug and a mesh of cross-linked fibrin protein. Blood flow to the heart, brain, lungs, and legs is blocked by clots. Blood clots can cause serious issues in the body, involving blood vessel damage, hypertension, stroke, and occasionally even death. Thrombosis is a substantial contributor to the death of cancer patients. Blood clots can be treated surgically or with anticoagulation drugs.
Market Drivers
The construction of cutting-edge next-generation thrombectomy tools and the speedy advancement of technology will promote the market introduction of clot management devices. As self-monitoring devices received rapid administrative approvals, the market share for clot supervision will also increase. One element in the expansion is the growing senior population, which is more prone to contracting such infections. The potential to minimize hospital investments and waiting times for low-risk lump extraction techniques is expected to expand throughout the projection period as a result of the increased demand for such procedures. Worldwide, 17.9 million people die from cardiovascular disorders each year, according to the World Health Organization (WHO). In addition, a rising demand for minimally invasive treatments for blood clots is predicted to boost market expansion due to the rising occurrence of heart attacks and stroke.
The market will increase in the next years as a result of increasing thrombectomy/embolectomy device demand and growing awareness of cutting-edge clot management procedures. Another significant element is the greater consciousness among patients and medical professionals of the benefits of percutaneous thrombectomy devices over the traditional technique of eliminating clots through open surgery.
Market Restraints
The lack of pay systems and consciousness of preventative medical checks to detect blood clotting, on the other hand, will impede the market's growth rate. The market for clot management devices will face challenges due to a shortage of highly qualified workers and a lack of healthcare infrastructure in emerging nations. Over the projected period, the expansion of the global market for clot management devices is anticipated to be constrained by the high cost of these devices. Many developing nations lack clearly defined reimbursement regulations, which can also impede the expansion of the market for clot management devices globally.
Market Segmentation
Global Clot Management Devices Market is segmented into Product and End-User. By Product Type such as Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices, and Inferior vena cava filters (IVCF), Percutaneous Thrombectomy Devices. By End-Use such as Hospitals, Diagnostic Centers, Others.
Regional Analysis
Global Clot Management Devices Market is segmented into five regions North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Due to the rising geriatric population as well as the adoption of cutting-edge medical technology, North America owns and controls the majority of the global market for clot management devices. Because of modifications in lifestyle and improved disposable income, rising prevalence of target diseases along with improved healthcare infrastructure, and the launch of technologically advanced goods, Asia-Pacific is predicted to grow at the greatest rate throughout the forecast period.
Key Players
This report includes a list of numerous Key Players, namely Angio Dynamics, Inc. (U.S.), Applied Medical Resources Corporation (U.S.), Bayer AG (Germany), Boston Scientific Corporation (U.S.), Edwards Lifesciences Corporation (U.S.), EKOS Corporation (U.S.), Janssen Pharmaceuticals, Inc. (U.S.), Medtronic (Ireland), Stryker (U.S.), Volcano Corporation (U.S.).
Market Taxonomy
By Product Type
By End User
By Region
Global Clot Management Devices Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Clot Management Devices Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Clot Management Devices Market, By Product Type
5.1 Y-o-Y Growth Comparison, By Product Type
5.2 Global Clot Management Devices Market Share Analysis, By Product Type
5.3 Global Clot Management Devices Market Size and Forecast, By Product Type
5.3.1 Percutaneous Thrombectomy Devices
5.3.2 Mechanical Thrombectomy
5.3.3 Aspiration Thrombectomy
5.3.4 Percutaneous Mechanical Thrombectomy (PMT)
5.3.5 Embolectomy Balloon Catheters
5.3.6 Catheter-Directed Thrombolysis (CDT) Devices
5.3.7 Inferior Vena Cava Filters (IVCFS)
5.3.8 Permanent
5.3.9 Retrievable
5.3.10 Neurovascular Embolectomy Devices
6 Global Clot Management Devices Market, By End-User
6.1 Y-o-Y Growth Comparison, By End-User
6.2 Global Clot Management Devices Market Share Analysis, By End-User
6.3 Global Clot Management Devices Market Size and Forecast, By End-User
6.3.1 Hospitals
6.3.2 Diagnostic Centers
6.3.3 Others
7 Global Clot Management Devices Market, By Region
7.1 Global Clot Management Devices Market Share Analysis, By Region
7.2 Global Clot Management Devices Market Share Analysis, By Region
7.3 Global Clot Management Devices Market Size and Forecast, By Region
8 North America Clot Management Devices Market Analysis and Forecast (2022-2027)
8.1 Introduction
8.2 North America Clot Management Devices Market Share Analysis, By Product Type
8.3 North America Clot Management Devices Market Size and Forecast, By End-User
8.4 North America Clot Management Devices Market Size and Forecast, By Country
8.4.1 U.S.
8.4.2 Canada
8.4.3 Mexico
9 Europe Clot Management Devices Market Analysis and Forecast (2022-2027)
9.1 Introduction
9.2 Europe Clot Management Devices Market Share Analysis, By Product Type
9.3 Europe Clot Management Devices Market Size and Forecast, By End-User
9.4 Europe Clot Management Devices Market Size and Forecast, By Country
9.4.1 Germany
9.4.2 France
9.4.3 UK
9.4.4. Rest of Europe
10 Asia Pacific Clot Management Devices Market Analysis and Forecast (2022-2027)
10.1 Introduction
10.2 Asia Pacific Clot Management Devices Market Share Analysis, By Product Type
10.3 Asia Pacific Clot Management Devices Market Size and Forecast, By End-User
10.4 Asia Pacific Clot Management Devices Market Size and Forecast, By Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4. Rest of Asia Pacific
11 Latin America Clot Management Devices Market Analysis and Forecast (2022-2027)
11.1 Introduction
11.2 Latin America Clot Management Devices Market Share Analysis, By Product Type
11.3 Latin America Clot Management Devices Market Size and Forecast, By End-User
11.4 Latin America Clot Management Devices Market Size and Forecast, Country
11.4.1. Brazil
11.4.2. Rest of Latin America
12 Middle East Clot Management Devices Market Analysis and Forecast (2022-2027)
12.1 Introduction
12.2 Middle East Clot Management Devices Market Share Analysis, By Product Type
12.3 Middle East Clot Management Devices Market Size and Forecast, By End-User
12.4 Middle East Clot Management Devices Market Size and Forecast, By Country
12.4.1. Saudi Arabia
12.4.2. UAE
12.4.3. Egypt
12.4.4. Kuwait
12.4.5. South Africa
13 Competitive Analysis
13.1 Competition Dashboard
13.2 Market share Analysis of Top Vendors
13.3 Key Development Strategies
14 Company Profiles
14.1 Angio Dynamics, Inc.
14.1.1 Overview
14.1.2 Offerings
14.1.3 Key Financials
14.1.4 Business Segment & Geographic Overview
14.1.5 Key Market Developments
14.1.6 Key Strategies
14.2 Applied Medical Resources Corporation
14.2.1 Overview
14.2.2 Offerings
14.2.3 Key Financials
14.2.4 Business Segment & Geographic Overview
14.2.5 Key Market Developments
14.2.6 Key Strategies
14.3 Bayer AG
14.3.1 Overview
14.3.2 Offerings
14.3.3 Key Financials
14.3.4 Business Segment & Geographic Overview
14.3.5 Key Market Developments
14.3.6 Key Strategies
14.4 Boston Scientific Corporation
14.4.1 Overview
14.4.2 Offerings
14.4.3 Key Financials
14.4.4 Business Segment & Geographic Overview
14.4.5 Key Market Developments
14.4.6 Key Strategies
14.5 Edwards Lifesciences Corporation
14.5.1 Overview
14.5.2 Offerings
14.5.3 Key Financials
14.5.4 Business Segment & Geographic Overview
14.5.5 Key Market Developments
14.5.6 Key Strategies
14.6 EKOS Corporation
14.6.1 Overview
14.6.2 Offerings
14.6.3 Key Financials
14.6.4 Business Segment & Geographic Overview
14.6.5 Key Market Developments
14.6.6 Key Strategies
14.7 Janssen Pharmaceuticals, Inc.
14.7.1 Overview
14.7.2 Offerings
14.7.3 Key Financials
14.7.4 Business Segment & Geographic Overview
14.7.5 Key Market Developments
14.7.6 Key Strategies
14.8 Medtronic
14.8.1 Overview
14.8.2 Offerings
14.8.3 Key Financials
14.8.4 Business Segment & Geographic Overview
14.8.5 Key Market Developments
14.8.6 Key Strategies
14.9 Stryker
14.9.1 Overview
14.9.2 Offerings
14.9.3 Key Financials
14.9.4 Business Segment & Geographic Overview
14.9.5 Key Market Developments
14.9.6 Key Strategies
14.10 Volcano Corporation
14.10.1 Overview
14.10.2 Offerings
14.10.3 Key Financials
14.10.4 Business Segment & Geographic Overview
14.10.5 Key Market Developments
14.10.6 Key Strategies
